Meet Our Board of Directors

Mr. Hennessey is Managing Director of Hennessey and Associates. Ltd., and is the former Chairman, President and CEO of Genome Therapeutics, currently named Oscient Pharmaceuticals, where he serves on the Board of Directors. He also held a number of executive positions with such industry leaders as Sterling, Abbott Laboratories, SmithKline, and Merck. He was also interim President and CEO of PenWest Pharmaceuticals.

Mr. Matthew is currently the CFO of DailyAccess Corporation, a privately-held provider of retirement services. His prior position was CFO and Secretary of Jesup & Lamont, Inc., a publicly held financial services firm. Previously, he also was CFO and Secretary of Plan Express, Inc., and at Polyvue Technologies, Inc. where he also was a member of the Board of Directors.

Mr. Butler is currently a Senior Advisor to Capnia, Inc. and recently served several roles at Reliant Pharmaceuticals, including Senior Vice President of Sales and Marketing.  He retired from ALZA Corporation where the last position he held was President of Alza International. Prior to that, Mr. Butler worked at Glaxo Inc. for 23 years where the last position he held was Vice President-General Manager of Corporate Division. He is currently on the Board of Directors of Invitrox and Sirion Therapeutics and is the Chairman of the Board of Directors of Respirics, Inc.  Past Board memberships include Durect Corporation, Biodelivery Sciences International, Pozen, Inc., and Osprey Pharmaceuticals.  Mr. Butler is on the Pharmacy School Board at the University of Florida and is on the Board of Advisors at Campbell University, North Carolina. Mr. Butler is also a principal in a start up pharmaceutical company called Apothogen Pharmaceuticals.

Mr. McConnell is a partner at the law firm of Murray, Seltzer & McConnell, LLP.  Additionally, he is the Director of Human Resources at Modern Business Associates, Inc. - a human resources outsourcing company with a nationwide client base.  Previously, he litigated in the area of labor and employment with Thompson, Sizemore & Gonzalez, P.A. in Tampa, Florida.

Dr. Kraus is currently Vice President at a major health information services company responsible for Corporate Strategy, Grants & Research, and Government Services, as well as the emerging pharmaceutical market related to drug safety and communication. He is board certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine. Pre-clinical research activities post fellowship at NIH focused on assay development for latent tuberculosis screening as well as reformulation of second line antibiotics (in partnership with GlaxoSmithKline and Eli Lilly). He had several years of regulatory experience at FDA/Office of Antimicrobial Products which included a broad range of anti-infective indications such as community-acquired bacterial pneumonia, skin and skin structure infections, and biothreat agents (anthrax, smallpox, and plague). Previously held scientific and management roles were with Adventist Healthcare (Director, Clinical Informatics, Director, Infection Control, Scientific Director & Institutional Review Board), Ingenix (Senior Director, Infectious Disease), and PRA International (Global Scientific Head, Infectious Diseases)

Mr. Stagnaro is an Independent Director with over 40 years of experience in the medical and biotechnology fields, including sales, marketing, management, and fund-raising positions. He is currently on the board of directors of Bio-Sim, Inc., LSRO (Life Sciences Research Organization, Inc.), and CosmosID Inc. His career includes positions as President and Chief Executive Officer of Americas Biotech Distributor, LLC; President and CEO of Agile Therapeutics, Inc., a pharmaceutical consultant with Rock Hill Ventures/Hillman Medical Ventures, President and CEO of 3-Dimensional Pharmaceuticals, Inc., Senior Executive Vice President of NABI Biopharmaceuticals, Inc.; and President and CEO of Univax Biologics, Inc., as well as other senior management positions. He is a member of the Board of Directors of the Singapore National Science Foundation and of the Board of Visitors for the University of Maryland Biotechnology Institute.